New research suggests that the impact of natural and vaccine-induced immunity will be key factors in shaping the future trajectory of the global coronavirus pandemic, known as COVID-19. In particular, a vaccine capable of eliciting a strong immune response could substantially reduce the future burden of infection, according to a study by Princeton researchers published in the journal Science Sept. 21.
While scientists race to develop and test a vaccine effective against SARS-CoV-2, the virus that causes COVID-19, recent studies have indicated that countries with widespread BCG vaccination appear to be weathering the pandemic better than their counterparts. This has led many researchers to suspect that BCG vaccine, which immunizes against tuberculosis, might offer protection against COVID-19.
Using patient data from Cleveland Clinic's COVID-19 registry, Dr. Joe Zein found that receiving the flu vaccine does not increase risk for COVID-19 or worsen associated disease outcomes, suggesting it is safe and advisable to receive the influenza vaccine this flu season.
Belief in conspiracy theories about the coronavirus pandemic was inversely related to the perceived threat of the pandemic; taking of preventive actions, including wearing a face mask; and the intention to be vaccinated when there is a COVID-19 vaccine. The research is based on two-wave panel study in March and July of 840 U.S. adults.
Scientists have used a new high-speed, in vitro selection method to isolate 9 antibody-like proteins (ALPs) that bind to the SARS-CoV-2 virus - 4 of which also exhibited neutralizing activity - within 4 days, according to a new study. While much research has
A CRISPR-based diagnostic for the SARS-Cov-2 virus can produce results in less than an hour with similar accuracy as the standard PCR test now used. Development of the Covid-19 test was led by researchers at MIT and the Broad Institute of MIT and Harvard.
All healthcare personnel should be immunized against vaccine preventable diseases recommended by U.S. Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices (CDC/ACIP) as a condition of employment, according to a new policy statement by the Society for Healthcare Epidemiology of America. The broad statement of support of the vaccination recommendations, published in the journal Infection Control and Hospital Epidemiology, suggests medical contraindications as the only exception to receiving recommended immunizations.
"Citizen scientists" developing homemade COVID-19 vaccines may believe they're inoculating themselves against the ongoing pandemic, but the practice of self-experimentation with do-it-yourself medical innovations is fraught with legal, ethical and public health issues, says a new paper co-written by University of Illinois law professor Jacob S. Sherkow.
A new study conducted by IVI in collaboration with SK bioscience shows that single-dose and two-dose regimens of Vi-DT typhoid conjugate vaccine (TCV) are safe and immunogenic in children 6-23 months of age, a group with high rates of typhoid fever in resource-limited settings.
A multi-layered, virus-specific immune response is important for controlling SARS-CoV-2 during the acute phase of the infection and reducing COVID-19 disease severity, with the bulk of the evidence pointing to a much bigger role for T cells than antibodies. A weak or uncoordinated immune response, on the other hand, predicts a poor disease outcome.